HighMark Wealth Management »

Centessa Pharmaceuticals shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.7M 167k 15.99
2024-06-30 $840k 93k 9.03

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Paragon 28 (FNA)
Performant Finl (PFMT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
AtriCure (ATRC)
Apple (AAPL)

View all positions for HighMark Wealth Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
EcoR1 Capital
T. Rowe Price Associates
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
TCG Crossover Management
Point72 Asset Management
Franklin Resources
Driehaus Capital Management
Avidity Partners Management
Morgan Stanley

View all funds holding Centessa Pharmaceuticals